Cargando…
Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies
AA amyloidosis results from the pathologic deposition in the kidneys and other organs of fibrils composed of N-terminal fragments of serum amyloid A protein (SAA). Given that there are only limited means to visualize these deposits, we have developed a series of mAbs, 2A4, 7D8, and 8G9, that bind sp...
Autores principales: | Wall, Jonathan S., Kennel, Stephen J., Richey, Tina, Allen, Amy, Stuckey, Alan, Weiss, Deborah T., Macy, Sallie D., Barbour, Robin, Seubert, Peter, Solomon, Alan, Schenk, Dale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341974/ https://www.ncbi.nlm.nih.gov/pubmed/22566822 http://dx.doi.org/10.3389/fimmu.2011.00032 |
Ejemplares similares
-
AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils
por: Wall, Jonathan S., et al.
Publicado: (2012) -
A Peptide-Fc Opsonin with Pan-Amyloid Reactivity
por: Foster, James S., et al.
Publicado: (2017) -
A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo
por: Wall, Jonathan S., et al.
Publicado: (2013) -
Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis
por: Martin, Emily B., et al.
Publicado: (2016) -
Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
por: Foster, James S., et al.
Publicado: (2023)